Annual Report

Overview

The report describes Zealand's 2016 transition toward a more sustainable biotech company, highlighted by U.S. approvals and launches of Adlyxin and Soliqua. Revenue reached DKK 234.8 million, driven mainly by milestone payments and royalties. The CSR agenda covered employee well-being, diversity, ethics, animal welfare and environmental sustainability.

Document

Report type: Annual Report
Class: Financial
Scope: Full report
Fiscal year: 2016
Period: 1 January 2016 – 31 December 2016
Publication date: 15 March 2017
Language: English
Pages
File size
Restatement: Disclosed

Data Services

Turn sustainability reports into a dataset built for your research.

From bulk PDFs to structured indicators and machine-readable documents.

View services